(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RADYSI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RADYSI

ST13

US500000079302743

Class

1, 5

Filing

79302743

Registration

6696061

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

12/06/2024

Trademark type

Word

Nice classes

1, 5

Filing date

12/14/2020

Registration date

04/12/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/12/2022

Last transaction

04/12/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

SE

Examiner

STRUCK, ROBERT J

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Ascelia Pharma AB

Representatives

Monica Riva Talley Sterne, Kessler, Goldstein & Fox PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use

Class 5

Pharmaceutical and veterinary preparations and substances used for medical purposesdiagnostic agentsdiagnostic reagentscontrast mediacontrast agents for use in medical diagnostic imaging in the nature of magnetic resonance imaging; contrast media and contrast agents for use in in-vivo imaging; contrast media and contrast agents for use in in-vitro imaging

Publications

History of USPTO decisions and trademark events.

26 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/06/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/20/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/26/2022

FIMP

FINAL DISPOSITION PROCESSED

08/26/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/12/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/12/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/25/2022

PUBO

PUBLISHED FOR OPPOSITION

01/25/2022

GPNX

NOTIFICATION PROCESSED BY IB

01/22/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/05/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/05/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/20/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/17/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/17/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/17/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/06/2021

RFNT

REFUSAL PROCESSED BY IB

06/28/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/08/2021

RFRR

REFUSAL PROCESSED BY MPU

06/08/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/08/2021

CNRT

NON-FINAL ACTION WRITTEN

06/07/2021

DOCK

ASSIGNED TO EXAMINER

06/07/2021

MAFR

APPLICATION FILING RECEIPT MAILED

01/26/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/22/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/21/2021

Continuous trademark protection

Get notified about every new filing that threatens RADYSI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.